Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Calin

Showing results (321-330 of 747) with videos related to

Pageof 75
Sort By:
Lancet (London, England)|December 23, 1989
Osteoporosis in early ankylosing spondylitis: a primary pathological event?R Will, R Palmer, A K Bhalla, et al.
Cancer Drug Resistance (Alhambra, Calif.)|December 24, 2019
The role of exosomal long non-coding RNAs in cancer drug resistanceMireia Cruz De Los Santos, Mihnea P Dragomir, George A Calin
Methods in Molecular Biology (Clifton, N.J.)|January 2, 2016
Profiling Long Noncoding RNA Expression Using Custom-Designed MicroarrayXinna Zhang, Gabriel Lopez-Berestein, Anil K Sood, et al.
Nature Reviews. Drug Discovery|June 19, 2021
Noncoding RNA therapeutics - challenges and potential solutionsMelanie Winkle, Sherien M El-Daly, Muller Fabbri, et al.
Chirurgia (Bucharest, Romania : 1990)|September 6, 2018
New Definitions of Sepsis and the Quest for Specific Biomarkers. Are the miRNAs the Answer?Gratiela Manga, George A Calin, Mircea Manuc, et al.
Expert Opinion on Biological Therapy|August 2, 2007
Regulatory mechanisms of microRNAs involvement in cancerMuller Fabbri, Mircea Ivan, Amelia Cimmino, et al.
Neuroscience|March 26, 2013
Peripheral motor axons of SOD1(G127X) mutant mice are susceptible to activity-dependent degenerationS Alvarez, A Calin, K S Graffmo, et al.
Advanced Drug Delivery Reviews|September 21, 2014
Small molecule compounds targeting miRNAs for cancer therapyPaloma Del C Monroig, Lu Chen, Shuxing Zhang, et al.
The FEBS Journal|January 30, 2017
Noncoding RNAs and immune checkpoints-clinical implications as cancer therapeuticsMaria A Smolle, Horatiu N Calin, Martin Pichler, et al.
The Western Journal of Medicine|June 1, 1980
Post-Yersinia ArthritisG F Williams, A Calin, S R Gospe, et al.
Pageof 75

Showing results (321-330 of 747) with videos related to

Sort By:
Pageof 75
Lancet (London, England)|December 23, 1989
Osteoporosis in early ankylosing spondylitis: a primary pathological event?R Will, R Palmer, A K Bhalla, et al.
Cancer Drug Resistance (Alhambra, Calif.)|December 24, 2019
The role of exosomal long non-coding RNAs in cancer drug resistanceMireia Cruz De Los Santos, Mihnea P Dragomir, George A Calin
Methods in Molecular Biology (Clifton, N.J.)|January 2, 2016
Profiling Long Noncoding RNA Expression Using Custom-Designed MicroarrayXinna Zhang, Gabriel Lopez-Berestein, Anil K Sood, et al.
Nature Reviews. Drug Discovery|June 19, 2021
Noncoding RNA therapeutics - challenges and potential solutionsMelanie Winkle, Sherien M El-Daly, Muller Fabbri, et al.
Chirurgia (Bucharest, Romania : 1990)|September 6, 2018
New Definitions of Sepsis and the Quest for Specific Biomarkers. Are the miRNAs the Answer?Gratiela Manga, George A Calin, Mircea Manuc, et al.
Expert Opinion on Biological Therapy|August 2, 2007
Regulatory mechanisms of microRNAs involvement in cancerMuller Fabbri, Mircea Ivan, Amelia Cimmino, et al.
Neuroscience|March 26, 2013
Peripheral motor axons of SOD1(G127X) mutant mice are susceptible to activity-dependent degenerationS Alvarez, A Calin, K S Graffmo, et al.
Advanced Drug Delivery Reviews|September 21, 2014
Small molecule compounds targeting miRNAs for cancer therapyPaloma Del C Monroig, Lu Chen, Shuxing Zhang, et al.
The FEBS Journal|January 30, 2017
Noncoding RNAs and immune checkpoints-clinical implications as cancer therapeuticsMaria A Smolle, Horatiu N Calin, Martin Pichler, et al.
The Western Journal of Medicine|June 1, 1980
Post-Yersinia ArthritisG F Williams, A Calin, S R Gospe, et al.
Pageof 75